Kinetics of Response to Conventional Treatment in Patients With Pemphigus Vulgaris

I t is difficult to evaluate the effectiveness of new therapies for pemphigus vulgaris (PV) because controlled trials are rarely performed. Comparison to historical trials is also problematic because little is known about the frequency and time it takes for active pemphigus to respond to conventional treatment. To address this problem, we evaluated the kinetics of response in PV to conventional treatment with prednisone.